Cotinga Pharmaceuticals, Inc. is a clinical stage biotechnology company. It engages in the business of utilizing proprietary artificial intelligence technologies to pursue a targeted and transformational approach in treating cancer and other unmet medical needs. The company was founded on October 13, 2006 and is headquartered in Boston, MA.